DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
310. 先天異常症候群
Congenital anomalies syndrome
Clinical trials
/
Disease details
臨床試験数
:
11
/
薬物数
:
20
- (
DrugBank
:
10
) /
標的遺伝子数
:
3
-
標的パスウェイ数
:
7
Search
1 trial found
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT00064792
(
ClinicalTrials.gov
)
July 2003
11/7/2003
Simvastatin Therapy in Smith-Lemli-Opitz Syndrome
Investigation of Simvastatin Therapy in Smith-Lemli-Opitz Syndrome
Smith-Lemli-Opitz Syndrome
Drug:
Simvastatin
Susp.
;Drug:
OraPlus
Forbes Porter, M.D.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Completed
4 Years
18 Years
All
23
Phase 2
United States